Ads
related to: pharmaceuticals
Search results
Shareholders May Be More Conservative With Mirum Pharmaceuticals, Inc.'s (NASDAQ:MIRM) CEO...
Simply Wall St. via Yahoo Finance· 1 day agoKey Insights Mirum Pharmaceuticals' Annual General Meeting to take place on 5th of June Total pay...
Vanda Pharmaceuticals Announces Participation in the Jefferies 2024 Global Healthcare Conference
The Sun Chronicle· 1 day agoVanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced that the company will participate in the Jefferies 2024 Global Healthcare Conference in New York City on ...
EU regulators back LIVMARLI for rare liver disorder By Investing.com
Investing.com· 6 hours agoMirum Pharmaceuticals, Inc. (NASDAQ:MIRM) received a positive opinion from the European Committee...
SciSparc secures European patent for antimicrobial method By Investing.com
Investing.com· 6 hours agoSciSparc Ltd. (NASDAQ:SPRC), a clinical-stage pharmaceutical company specializing in central nervous...
Vanda Pharmaceuticals Announces Completion of Transfer of FDA Marketing Authorization for PONVORY®
The Woonsocket Call· 1 day agoVanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced that ownership of the U.S. New Drug Application and Investigational New Drug Applications for PONVORY® (ponesimod ...
Swiss biotech ecosystem recuperates from global financial instability
Pharmaceutical Technology via Yahoo Finance· 9 hours agoIn 2023, the Swiss Biotech Association reported that the life sciences sector—pharmaceuticals,...
Momentum for drug discount program reform
Politico· 1 day agoWith Carmen Paun 340B IN THE CROSSHAIRS — A bipartisan and pharmaceutical industry-backed push in Congress to reform the controversial 340B drug discount ...
Lexicon Pharmaceuticals maintains stock target, Overweight rating By Investing.com
Investing.com· 8 hours agoOn Friday, Piper Sandler reaffirmed its positive stance on Lexicon Pharmaceuticals (NASDAQ:LXRX),...
CNS Pharmaceuticals, Inc. (NASDAQ:CNSP) Short Interest Up 100.3% in May
ETF DAILY NEWS· 20 hours agoCNS Pharmaceuticals, Inc. (NASDAQ:CNSP – Get Free Report) was the recipient of a large increase in short interest during the month of May. As of May 15th, there was short ...
4 Analysts Assess Teva Pharmaceutical Indus: What You Need To Know - Teva Pharmaceutical Indus...
Benzinga· 1 day agoLoading... Loading... In the latest quarter, 4 analysts provided ratings for Teva Pharmaceutical Indus TEVA , showcasing a mix of bullish and bearish perspectives. The following ...
